The value of a patient-first approach and telehealth for addressing the complex health coordination needs of those with these pulmonary conditions has never been more critical.
Rare lung diseases, defined as those that affect fewer than 200,000 individuals, affect a wide array of individuals.1
These diseases include a spectrum of disorders, including alpha-1 antitrypsin deficiency (Alpha-1), hereditary interstitial lung diseases, lymphangioleimyomatosis, pulmonary alveolar proteinosis, and tuberous sclerosis.
To read more, Click Here.
